GB1287602A - 4,6-DICHLORO-Delta<4.6>-OESTRADIENES - Google Patents
4,6-DICHLORO-Delta<4.6>-OESTRADIENESInfo
- Publication number
- GB1287602A GB1287602A GB44022/69A GB4402269A GB1287602A GB 1287602 A GB1287602 A GB 1287602A GB 44022/69 A GB44022/69 A GB 44022/69A GB 4402269 A GB4402269 A GB 4402269A GB 1287602 A GB1287602 A GB 1287602A
- Authority
- GB
- United Kingdom
- Prior art keywords
- sept
- oestradienes
- dichloro
- delta
- progestational
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 abstract 2
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 239000003433 contraceptive agent Substances 0.000 abstract 1
- 230000002254 contraceptive effect Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229940011871 estrogen Drugs 0.000 abstract 1
- 239000000262 estrogen Substances 0.000 abstract 1
- 229960002568 ethinylestradiol Drugs 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 230000001072 progestational effect Effects 0.000 abstract 1
- 229960003387 progesterone Drugs 0.000 abstract 1
- 239000000186 progesterone Substances 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
1287602 Progestational medicines SCHERING AG 5 Sept 1969 [13 Sept 1968] 44022/69 Heading A5B [Also in Division C2] Pharmaceutical preparations comprise racemic or optically active steroids having progesterone activity of the formula: (wherein R is H, acyl, alkyl or tetrahydropyranyl) and suitable carriers. They may be used in combination with an estrogen such as ethynyl-estradiol. Contraceptive use is among those referred to.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19681793422 DE1793422C3 (en) | 1968-09-13 | 4,6-dichloro-4,6-estradienes, processes for their preparation and medicaments containing them, as well as rac-u.nat. 6-chloro-lTbeta-acetoxy-ie-methyl-17a-ethinyl-4,6-estradien-3-one as starting compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1287602A true GB1287602A (en) | 1972-09-06 |
Family
ID=5707698
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB44022/69A Expired GB1287602A (en) | 1968-09-13 | 1969-09-05 | 4,6-DICHLORO-Delta<4.6>-OESTRADIENES |
Country Status (12)
Country | Link |
---|---|
US (1) | US3812166A (en) |
AT (1) | AT289307B (en) |
BE (1) | BE738803A (en) |
BR (1) | BR6912323D0 (en) |
CH (1) | CH536294A (en) |
DK (1) | DK121656B (en) |
ES (1) | ES370887A1 (en) |
FR (1) | FR2018070A1 (en) |
GB (1) | GB1287602A (en) |
IL (1) | IL32973A (en) |
NL (1) | NL164041C (en) |
SE (1) | SE352080B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0111872D0 (en) * | 2001-05-15 | 2001-07-04 | Northwick Park Inst For Medica | Therapeutic agents and methods |
US7968605B2 (en) * | 2002-02-04 | 2011-06-28 | ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
US20080026984A1 (en) * | 2002-02-04 | 2008-01-31 | Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
AU2003208525B9 (en) * | 2002-02-04 | 2009-08-27 | Alfama-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda | Amend the invention title to read Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof |
GB2395432B (en) * | 2002-11-20 | 2005-09-14 | Northwick Park Inst For Medica | Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs |
GB0601394D0 (en) | 2006-01-24 | 2006-03-01 | Hemocorm Ltd | Therapeutic delivery of carbon monoxide |
EP2699242B1 (en) | 2011-04-19 | 2017-11-01 | Alfama, Inc. | Carbon monoxide releasing molecules and uses thereof |
EP2734235B1 (en) | 2011-07-21 | 2017-03-22 | Alfama, Inc. | Ruthenium carbon monoxide releasing molecules and uses thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH499505A (en) * | 1966-02-23 | 1970-11-30 | Hoffmann La Roche | Steroids of the partial formula (I):- where R1 is halogen (at wt.100) or alkyl Q is oxo or 1,2-alkylenedioxy (2-4C) M is the remainder of the |
-
1969
- 1969-08-05 CH CH1186569A patent/CH536294A/en not_active IP Right Cessation
- 1969-08-26 ES ES370887A patent/ES370887A1/en not_active Expired
- 1969-08-27 US US00853480A patent/US3812166A/en not_active Expired - Lifetime
- 1969-09-02 DK DK469169AA patent/DK121656B/en not_active IP Right Cessation
- 1969-09-05 AT AT847669A patent/AT289307B/en not_active IP Right Cessation
- 1969-09-05 GB GB44022/69A patent/GB1287602A/en not_active Expired
- 1969-09-09 IL IL32973A patent/IL32973A/en unknown
- 1969-09-10 BR BR212323/69A patent/BR6912323D0/en unknown
- 1969-09-12 NL NL6913959.A patent/NL164041C/en not_active IP Right Cessation
- 1969-09-12 FR FR6931175A patent/FR2018070A1/fr not_active Withdrawn
- 1969-09-12 SE SE12600/69A patent/SE352080B/xx unknown
- 1969-09-12 BE BE738803D patent/BE738803A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ES370887A1 (en) | 1971-07-01 |
NL164041B (en) | 1980-06-16 |
CH536294A (en) | 1973-04-30 |
US3812166A (en) | 1974-05-21 |
NL6913959A (en) | 1970-03-17 |
IL32973A0 (en) | 1969-11-30 |
SE352080B (en) | 1972-12-18 |
DE1793422A1 (en) | 1971-07-01 |
FR2018070A1 (en) | 1970-05-29 |
BR6912323D0 (en) | 1973-03-13 |
BE738803A (en) | 1970-03-12 |
NL164041C (en) | 1980-11-17 |
DE1793422B2 (en) | 1977-01-20 |
IL32973A (en) | 1974-07-31 |
DK121656B (en) | 1971-11-15 |
AT289307B (en) | 1971-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1464388A (en) | Preparations containing microencapsulated substances and process | |
GB1287602A (en) | 4,6-DICHLORO-Delta<4.6>-OESTRADIENES | |
IE33230B1 (en) | Anti-haemorrhoidally active preparations for local or rectal administration | |
GB1212704A (en) | Vaginal suppositories | |
GB1261989A (en) | 5-thiazolecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing the same | |
GB1125924A (en) | Organic bismuth derivative | |
GB1164705A (en) | Preparation of Delta<7>-Dehydro Steroids | |
ZA711290B (en) | Novel 16-methylene-9beta,10alpha steroid compounds,pharmaceutical preparations which contain the novel compounds as active ingredients,and methods of producing the said compounds and preparations | |
GB1215164A (en) | 21-sulphonated pregnadienes | |
CA833022A (en) | (lower) alkyl esters of 1,4-dihydroquinoline-n-carboxylic acid and 1,4-dihydroquinoline-n-thioncarboxylic acid | |
GB1145393A (en) | Improvements in or relating to 17-‡-(alka-1',3'-diynyl)-steroids | |
AU255425B2 (en) | Derivatives of 10, 11-dihydrodibendz azepine and pharmaceutical preparations thereof | |
CA618041A (en) | 1,3-diimino-2-nitropropyl-n',n"-p-dibenzoic acid and derivatives thereof | |
GB1159174A (en) | Pharmaceutical Compositions | |
CA536232A (en) | Preparation of cortisone and reichstein's substances from allosteroids | |
ES459520A1 (en) | D-homosteroids | |
CA851687A (en) | Pharmaceutical composition containing 4,7-phenanthrolin-5,6-quinone, pancreatin, bromelin, dehydrocholic acid and 7-iodo-5-chloro-8-hydroxyquinoline | |
CA621751A (en) | Composition for preparation of burow's solution | |
AU1152261A (en) | Derivatives of 10, 11-dihydrodibendz azepine and pharmaceutical preparations thereof | |
AU252852B2 (en) | Biologically active complex polysaccharide and preparation thereof | |
GB1157912A (en) | Derivatives of Vernamycin B | |
AU260025B2 (en) | New camphorated derivatives of 2-aminothiazoline and their process of. preparation | |
AU413460B2 (en) | NOVEL DERIVATIVES OF 6,6,9-TRI-LOWER ALKYL-9-AZABICYCLO [3,3,1] NONAN-3-OR-3b-OL AND PREPARATION THEREOF | |
CA784221A (en) | Derivatives of glycyrrhetinic acid and process for the preparation thereof | |
AU6646765A (en) | Improvements in and relating to novel spirol-acetones of the steroid series, novel methods of producing said compounds and pharmaceutical preparations containing said compounds as active substances |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed [section 19, patents act 1949] | ||
PCNP | Patent ceased through non-payment of renewal fee |